⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRNA News
Moderna, Inc. Common Stock
How Moderna Uses Decision Intelligence to Enable an Autonomous Cold Chain, Upcoming Webinar Hosted by Xtalks
prnewswire.com
MRNA
Dash Bio Expands Operations with 24,000 Square Foot GLP-Compliant Facility in Waltham, MA. February 3, 2026
prnewswire.com
MRNA
COVID-19 Diagnostic Research Report 2026: Market Forecast 2025-2029 with Executive and Consultant Guides
globenewswire.com
ABT
BDX
BIO
CDNA
CUE
DHR
GILD
HOLX
ILMN
JNJ
LAB
LMT
LULU
MRNA
ON
ORGO
OTIS
PFE
QCOM
QGEN
QDEL
REGN
RTX
SIGA
SNPS
TCOM
TDOC
TEVA
TMO
TSLA
VRTX
XOM
Cancer Immunotherapy Research Report 2026: Market Forecasts 2025-2029 for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer with Executive and Consultant Guides
globenewswire.com
ABBV
ADAG
ADAP
ACET
ALXO
AMBR
AMGN
RCUS
AZN
ATRC
BBLU
BIIB
BNTX
BOLT
BMY
CRBU
CLDX
CRVS
LLY
EVAX
GNSS
GILD
GLSI
IMUX
IMMX
IMNM
INCY
INDP
ISRL
IOBT
JNJ
MRK
MRNA
MBIO
NVS
NVX
PDSB
PFE
REGN
SNY
SNT
URGN
ZYME
Antimicrobial Resistance Diagnostic Research Report 2026: Markets, Strategies, Trends and Forecasts 2025-2029 by Pathogen and Technology with Executive Guides and Customization
globenewswire.com
BIOX
MRNA
PFE
TMO
ILMN
QGEN
DGX
ABT
BDX
HOLX
EXAS
DHR
Syndromic Multiplex Panels Market Strategies, Trends and Forecast 2025-2029: Cost Efficiency, Diagnostic Accuracy, Single-Visit Testing, and Pandemic-Driven Uptake Support Growth
globenewswire.com
ABT
BDX
BIIB
CHE
CTAS
CUE
DHR
DIA
EXPE
GEHC
GILD
HOLX
ICUI
ILMN
INCY
ISRG
LH
LULU
MRNA
NBIX
NOC
ORCL
PDD
PFE
QGEN
QDEL
REGN
ROKU
SNPS
TMO
TSLA
VRTX
XRAY
Xtalks Announces its Life Science Webinar Calendar for February 2026
prnewswire.com
MRNA
Dr. David Berman to Join Moderna as Chief Development Officer
accessnewswire.com
MRNA
RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA
globenewswire.com
MRNA
Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927)
accessnewswire.com
MRNA